Name: SARS-CoV-2 Test
Brand: Seegene

Browse Products by Category

Covid-19 Seegene

Clinical Laboratory

SARS-CoV-2 Variants Assay
Allplex SARS-CoV-2 Variants II Assay

The Allplex SARS-CoV-2 Variants II Assay is intended for the simultaneous detection of four mutation sites in S gene for identification of SARS-CoV-2 variants. The multiplex real-time PCR assay detects and identifies four notable SARS-CoV-2 S gene mutations (L452R, W152C, K417T, and K417N) in a single tube.

More details

SARS-CoV-2 Variants Assay
Novaplex SARS-CoV-2 Variants IV Assay

The Novaplex SARS-CoV-2 Variants IV Assay is a real-time reverse transcriptase polymerase chain reaction (RT-PCR) test intended for the qualitative detection and differentiation of SARS-CoV-2 viral nucleic acids and Delta variants. The multiplex real-time PCR assay is designed to detect and differentiate mutations in a single tube, and is applied on Seegene’s integrated All-in-One automated platform which enables high-throughput testing.

More details

Liquid Handling Workstation
AdvanSure E3 SYSTEM

The AdvanSure E3 SYSTEM is an easy-to-use liquid handling workstation for handling primary sample tube to nucleic acid (NA) extraction. It provides a convenient process for your laboratory workflow by minimizing hands-on time and maximizing assay reliability.

More details

SARS-CoV-2 Variants Assay
Allplex SARS-CoV-2 Variants I Assay

The Allplex SARS-CoV-2 Variants I Assay is intended for the detection and differentiation of three mutation sites in S gene for the identification of SARS-CoV-2 variants.

More details

SARS-CoV-2 Master Assay
Allplex SARS-CoV-2 Master Assay

The Allplex SARS-CoV-2 Master Assay is intended for the full screening for SARS-CoV-2 and variants, including the five notable mutations in the S gene. It can be used alone or expanded to syndromic test with respiratory essential panel for common respiratory infections, including influenza A and B, metapneumovirus, parainfluenza virus 1/2/3/4, adenovirus, rhinovirus A/B/C and respiratory syncytial virus A/B, to provide more insights for diagnosis of symptomatic patients, especially with the emerging SARS-CoV-2 variants.

More details

SARS-CoV-2 Test
Allplex 2019-nCoV Assay

The Allplex 2019-nCoV Assay is a multiplex Real-time PCR assay for the simultaneous detection of three target genes of SARS-CoV-2 in a single tube. The assay is designed to detect RdRP and N genes specific for SARS-CoV-2, and E gene for all of Sarbecovirus, including SARS-CoV-2.

More details

SARS-CoV-2 Test
Allplex SARS-CoV-2 Assay

The Allplex SARS-CoV-2 Assay is a multiplex real-time PCR assay to detect four target genes of SARS-CoV-2, causing COVID-19 in a single tube. The assay is designed to detect RdRP, S and N genes specific for SARS-CoV-2, and E gene for all of Sarbecovirus including SARS-CoV-2. It can be applied on Seegene’s automated system that enables high throughput testing.

More details

SARS-CoV-2/FluA/FluB/RSV Test
Allplex SARS-CoV-2/FluA/FluB/RSV Assay

The Allplex SARS-CoV-2/Flu A/Flu B/RSV Assay is a multiplex real-time PCR assay designed to detect N gene, RdRP gene and S gene for SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) A/B in a single tube. The assay is applied on Seegene’s integrated All-in-One automated platform which enables high-throughput testing.

More details

News of Seegene

Seegene Unveils Combination Test at ECCMID 2018

19 Apr 2018

Seegene Inc., a developer of multiplex PCR technologies, introduced a combination test at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) held in Madrid, Spain, from April 21 to 24, 2018. The combination test is a high-efficiency solution that diagnoses various causes of diseases with multiplex molecular diagnosis assays. Seegene also showcased its molecular diagnostic system SGSTAR (Seegene Sameday Test and Report), which allows order-to-report on the same day and enables the running of the combination test.

Seegene Develops World’s First Multiplex MDx Assays with AI System

09 Jan 2018

Seegene Inc., a developer of multiplex PCR technologies, successfully developed molecular diagnostics (MDx) assays in just four days using an artificial intelligence- (AI) based automated assay development system. These assays are high multiplex real-time PCR reagents developed completely by AI and are meant for the simultaneous detection of eight different DNA targets for each of meningitis and sexually transmitted infections.

Seegene Partners with Hamilton to Develop Random Access System

28 Sep 2017

Seegene, a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx), has signed a Memorandum of Understanding (MoU) with Hamilton Company, which designs and manufactures precision measurement devices, automated liquid handling workstations, and sample management systems, to develop the Seegene Random Access System.

Seegene Collaborates with Thermo to Enter US Market

29 May 2017

Seegene Inc., a developer of multiplex molecular diagnostics technologies and assays, has entered into a collaboration with Thermo Fisher Scientific, in which Seegene will file for U.S. Food and Drug Administration (FDA) clearance of its Allplex diagnostic assay portfolio at the same time that Thermo Fisher files for FDA clearance to run Seegene's assays on Thermo Fisher's QuantStudio 5 Real-Time PCR System (PCR System).

SARS-CoV-2 Test

Model:

Allplex 2019-nCoV Assay

Request Information

Description:

Featured In:

Tags: [Clinical Laboratory], [Rapid Tests]

More Products From This Supplier

	* Required Information
	Logged in as
* Email	Already registered
Password	Wrong Password. If you have forgot password please click here.
To	Seegene (SARS-CoV-2 Test)
* Message

Member Login

Browse Products by Category

Browse Products by Category

Seegene

Covid-19 Seegene

Clinical Laboratory

News of Seegene

About Seegene

SARS-CoV-2 Test

Description:

Features

Send A Message To This Supplier

More Products From This Supplier